Research Topics
| Lea S EilandSummaryAffiliation: College of Veterinary Medicine Country: USA Publications
| Collaborators
|
Detail Information
Publications
Glycopyrrolate for chronic drooling in childrenLea S Eiland
Department of Pharmacy Practice, Auburn University Harrison School of Pharmacy, Huntsville, AL 35801, USA
Clin Ther 34:735-42. 2012..However, an oral solution was approved by the US Food and Drug Administration for children ages 3 to 16 years with neurologic disorders for chronic severe drooling in 2010; it became available for use in 2011...- Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patientsLea S Eiland
Auburn University Harrison School of Pharmacy, Huntsville, AL, USA
Ann Pharmacother 45:582-9. 2011..Although these recommendations are not specific to pediatrics, the principles can be extrapolated. Desired higher trough serum concentrations will require escalated dosages of vancomycin in children... - The use of triptans for pediatric migrainesLea S Eiland
Auburn University Harrison School of Pharmacy, Huntsville, Alabama, USA
Paediatr Drugs 12:379-89. 2010..Of the available triptans, there are more positive efficacy data for sumatriptan and zolmitriptan nasal sprays, and rizatriptan and almotriptan tablets than for the other triptans... 
Atomoxetine treatment of attention-deficit/hyperactivity disorderLea S Eiland
Harrison School of Pharmacy, Auburn University, Huntsville, AL 35801, USA
Ann Pharmacother 38:86-90. 2004..To review the literature of the first nonstimulant approved for treatment of attention-deficit/hyperactivity disorder (ADHD)...- Caregivers' perspectives when evaluating nonprescription medication utilization in childrenLea S Eiland
Department of Pharmacy Practice, Division of Pediatrics, Auburn University Harrison School of Pharmacy
Clin Pediatr (Phila) 47:578-87. 2008..Health care professionals should be knowledgeable on the appropriate use of medication. There is a significant need to question and to educate caregivers on nonprescription medication use in children... - Anticonvulsant use for prophylaxis of the pediatric migraineLea S Eiland
Pharmacy Practice Department, Harrison School of Pharmacy, Auburn University, Huntsville, Ala, USA
J Pediatr Health Care 21:392-5; quiz 396-8. 2007 - Pediatric migraine: pharmacologic agents for prophylaxisLea S Eiland
Auburn University Harrison School of Pharmacy, Huntsville, AL, USA
Ann Pharmacother 41:1181-90. 2007..To identify and evaluate the data regarding medication use for migraine prophylaxis in the pediatric population... - Evaluating the off-label use of medications in childrenLea S Eiland
Harrison School of Pharmacy, Auburn University, AL, USA
Am J Health Syst Pharm 63:1062-5. 2006 - Use of second-generation antiepileptic drugs in the pediatric populationAllison M Chung
Harrison School of Pharmacy, Pharmacy Practice, Auburn University, Auburn, Alabama, USA
Paediatr Drugs 10:217-54. 2008..Vigabatrin and rufinamide are currently not available in the US, but have been shown to have some success in other countries. Pregabalin is the newest antiepileptic agent, but lacks pediatric data currently... - Caregivers' baseline understanding and expectations of antibiotic use for their childrenMaria L Salazar
University of Alabama at Birmingham School of Medicine, Huntsville Regional Medical Campus, Huntsville, AL 35801, USA
Clin Pediatr (Phila) 51:632-7. 2012..This study showed that demographic variables play a role in caregivers' expectations of antibiotic use. Effective communication of physicians with caregivers on antibiotic use can be an important strategy to improve patient compliance...